![PDF) A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience PDF) A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience](https://www.researchgate.net/publication/362805329/figure/tbl1/AS:11431281092886136@1667009108271/Summary-of-DTaP-IPV-or-Tetraxim-immunogenicity-and-safety-clinical-studies-for-the_Q320.jpg)
PDF) A combined DTaP-IPV vaccine (Tetraxim®/Tetravac®) used as school-entry booster: a review of more than 20 years of clinical and post-marketing experience
![Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority,](https://www.thelancet.com/cms/asset/76230417-f64b-44e0-88c0-fc723ea79dcf/gr1.gif)
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority,
Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial | PLOS Medicine
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial: Human Vaccines: Vol 5, No 5
![Sanofi Pasteur launches first full-dose DtaP- IPV booster vaccine in India for preschoolers | Health Tips and News Sanofi Pasteur launches first full-dose DtaP- IPV booster vaccine in India for preschoolers | Health Tips and News](https://imgk.timesnownews.com/story/sanofi-vaccine.gif?tr=w-400,h-300,fo-auto)